Addition of selected covariates (age, male sex, estimated glomerular filtration rate ≤60 ml/min, previous myocardial infarction, left ventricular ejection fraction <40%, drug-eluting stent placement, SYNTAX score, hypertension, and diabetes mellitus) to the model did not change the predictive significance of a cTnI level of ≥70 × URL in terms of 5-year all-cause mortality or cardiovascular mortality (adjusted HR 2.45, 95% CI 1.20–5.02, P for trend 0.032 and adjusted HR 3.17, 95% CI 1.31–7.67, P for trend 0.015, respectively). This evidence concerns the gene TNNI3 and hypertensive disorder.